| 000 | 01219 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513204958.0 | ||
| 264 | 0 | _c20000509 | |
| 008 | 200005s 0 0 pol d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMałyszko, J S | |
| 245 | 0 | 0 |
_a[Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome]. _h[electronic resource] |
| 260 |
_bPolskie Archiwum Medycyny Wewnetrznej _cApr 1999 |
||
| 300 |
_a301-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aFactor VII _xmetabolism |
| 650 | 0 | 4 |
_aFactor X _xmetabolism |
| 650 | 0 | 4 | _aFactor Xa Inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoproteins _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xmetabolism |
| 650 | 0 | 4 |
_aThrombomodulin _xmetabolism |
| 650 | 0 | 4 |
_aThromboplastin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVitronectin _xmetabolism |
| 700 | 1 | _aMałyszko, J | |
| 700 | 1 | _aMyśliwiec, M | |
| 773 | 0 |
_tPolskie Archiwum Medycyny Wewnetrznej _gvol. 101 _gno. 4 _gp. 301-5 |
|
| 999 |
_c10693837 _d10693837 |
||